RVMD Return on Tangible Equity | Revolution Medicines, Inc.

Revolution Medicines, Inc. (RVMD) Return on Tangible Equity

2026-06-30: Return Tang Equity -68.23%.
2026-03-31: Return Tang Equity -92.35%.
2025-12-31: Return Tang Equity -69.98%.
2025-09-30: Return Tang Equity -60.74%.

Complete source-backed return tang equity history.

Available history: 2018-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-68.23%
2026-03-31	-92.35%
2025-12-31	-69.98%
2025-09-30	-60.74%
2025-06-30	-43.89%
2025-03-31	-33.81%
2024-12-31	-26.67%
2024-09-30	-36.57%
2024-06-30	-32.39%
2024-03-31	-28.33%
2023-12-31	-24.11%
2023-09-30	-40.38%
2023-06-30	-32.42%
2023-03-31	-27.72%
2022-12-31	-37.26%
2022-09-30	-36.90%
2022-06-30	-46.70%
2022-03-31	-38.97%
2021-12-31	-32.04%
2021-09-30	-27.23%
2021-06-30	-21.46%
2021-03-31	-17.89%
2020-12-31	-23.78%
2020-09-30	-18.26%
2020-06-30	-21.79%
2020-03-31	-15.64%
2019-12-31	27.49%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-69.98%
2024-12-31	-26.67%
2023-12-31	-24.11%
2022-12-31	-37.26%
2021-12-31	-32.04%
2020-12-31	-23.78%
2019-12-31	27.49%
2018-12-31	38.54%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
BIOGEN INC. (BIIB)	United States	$33.427B	19.60
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29